reboxetine has been researched along with amibegron in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (amibegron) | Trials (amibegron) | Recent Studies (post-2010) (amibegron) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 60 | 0 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubin, N; Avenet, P; Bougault, I; Busch, S; Chen, Y; Claustre, Y; Desvignes, C; Didier, M; Keane, P; Le Fur, G; Leonetti, M; Oury-Donat, F; Palejwala, V; Rouquier, L; Santucci, V; Scatton, B; Steinberg, R; Tocci, M; Yamdagni, P | 1 |
1 other study(ies) available for reboxetine and amibegron
| Article | Year |
|---|---|
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.
Topics: Action Potentials; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Brain; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Fluoxetine; Male; Mice; Microdialysis; Morpholines; Motor Activity; Neurons; Norepinephrine; Rats; Reboxetine; Receptors, Adrenergic, beta-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrahydronaphthalenes; Tryptophan | 2008 |